Ilumetri®
Product Description
Ilumetri is a medicine that acts on the immune system and is used to treat plaque psoriasis, a disease causing red, scaly patches on the skin. It is used in adults with moderate to severe disease for whom treatments applied to the skin are not suitable.
Ilumetri is available as a solution for injection in pre-filled syringes and pre-filled pens (autoinjectors). Each pre-filled syringe or pen contains 100 mg of tildrakizumab. Tildrakizumab is a monoclonal antibody (a type of protein) which is designed to attach to interleukin 23 and block its activity.
Launched Markets
Taiwan, Hong Kong and Macau
The information on this page is provided for general informational purposes only and is not intended to promote, advertise, or recommend the use of any specific pharmaceutical product, medical device, or treatment. It is not a substitute for professional medical advice, diagnosis, or treatment.
Product availability, indications, and regulatory status may vary by country and are subject to local laws and health authority approvals. Prescription products mentioned here are intended for reference purposes only and should not be purchased, used, or administered without consultation with, and prescription by, a qualified healthcare professional.
Please consult your physician, pharmacist, or other qualified healthcare provider for advice regarding any medical condition or before using any product referenced on this website.
